VS
Vandana Singh Dhakrey
About Vandana Singh Dhakrey
Data last updated:
Vandana Singh Dhakrey is a Director at Daylon India Private Limited (since 2026) and Director at Divianna Pharmaceuticals Private Limited (since 2024). The companies operate in Pharma.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Daylon India Private Limited U20237MR2026PTC478342 | Director | 10 Jul 2026 | 2026 | Active | |
| Divianna Pharmaceuticals Private Limited U47721MH2024PTC424884 | Director | 10 May 2024 | 2024 | Active |
Board colleagues of Vandana Singh Dhakrey
| Name | DIN | Company | Designation |
|---|---|---|---|
| Bhoori Singh Dhakrey | 09552496 | Daylon India Private Limited | Director |
| Tina Khatwar | 11818259 | Daylon India Private Limited | Director |
| Rakesh Kumar Soni | 10620902 | Divianna Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Vandana Singh Dhakrey
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vandana Singh Dhakrey
Vandana Singh Dhakrey currently holds 2 directorships: Daylon India Private Limited (Director, since 10 Jul 2026); Divianna Pharmaceuticals Private Limited (Director, since 10 May 2024).
Vandana Singh Dhakrey was first appointed on 10 May 2024 as Director at Divianna Pharmaceuticals Private Limited. The most recent appointment on record is 10 Jul 2026 at Daylon India Private Limited.
The current boards of Vandana Singh Dhakrey's companies include Bhoori Singh Dhakrey (Daylon India Private Limited), Tina Khatwar (Daylon India Private Limited), Rakesh Kumar Soni (Divianna Pharmaceuticals Private Limited).